A dispensary inside a Maitland medical centre and a shopping centre pharmacy at Kotara or Charlestown are each priced against sales of pharmacies like it. Who may buy, where the business may dispense from and how long the lease runs all shape that price.
Community pharmacies in Newcastle and the Hunter are valued mainly on comparable sales, because a closed group of eligible pharmacist buyers trades them regularly. We apply the multiple those sales support to earnings after a market salary for the owner-pharmacist, then test it against script volumes, the mix of PBS, front-of-shop and services income, stock and the lease.
Ownership is usually about to move. A pharmacist in Hamilton wants to bring an employed pharmacist in as a partner. An owner in a Lake Macquarie shopping centre has an offer from a buyer who already holds several stores. Two partners in a Port Stephens pharmacy cannot agree what one should pay the other to leave. A separating owner needs the pharmacy valued at a fixed date for a property settlement, or the accountant is restructuring and needs a value the ATO will accept. And when a pharmacist dies, the executors need a value and a buyer who is allowed to own a pharmacy, which narrows the field from the start.
In each case the other party tends to know the numbers well. Pharmacy buyers are pharmacists, often with a store or two already and a clear view of which measures to mark down. A broker's rule of thumb is a weak position to negotiate from; a reasoned valuation prepared before the first offer is a far stronger one.
The Market Approach leads. Because ownership is restricted and dispensing needs federal approval, pharmacies trade within a small, well-informed group of buyers, and the prices that group agrees are the best evidence of value.
We sort the comparable sales by site type before anything else: medical centre, supermarket-anchored shopping centre, strip shop or country town. Within the right group, sales are matched on script numbers, revenue mix, trading hours and lease, and under the guideline transactions method the multiple they support is applied to maintainable earnings.
Capitalised earnings is the main cross-check, and it carries real weight where dispensing is steady. The adjustment that moves the result most is the owner's own pay: in many pharmacies the reported profit includes a pharmacist's wage, and we take it out at market rates for the hours the owner actually works in the dispensary.
We look at the business as if a pharmacist had to be hired to replace the owner. The cost of that pharmacist, at market pay for the hours the owner works, comes off earnings first, and in an owner-run store it is often the largest single adjustment.
Stock goes in at realisable value, with expired, short-dated and slow lines written down, and the fit-out, dispensary robot and equipment at today's market value. In many pharmacy sales stock is the figure most argued over, so the count and the write-downs are shown line by line.
Different valuations of the same pharmacy usually diverge at this point, so every adjustment appears in the report body with its reason. For a pharmacy they are typically:
Two layers of regulation shape what a Hunter pharmacy buyer acquires. In New South Wales the Pharmacy Council of NSW regulates who may own a pharmacy business: ownership is limited mainly to pharmacists, and there is a cap on how many pharmacies one owner may hold, so every buyer has to qualify before settlement. Federally, dispensing under the Pharmaceutical Benefits Scheme requires approval as a PBS supplier at the premises (Source: Department of Health, Disability and Ageing, PBS approved suppliers). Together they narrow the buyer pool and make it hard for a competitor to open close by, which supports value.
Site type divides the comparables more sharply than suburb does. A pharmacy inside a medical centre in Maitland's newer suburbs relies on the GPs in the building and on that one tenancy. A pharmacy in a large shopping centre such as those at Kotara or Charlestown typically pays a percentage rent and trades the centre's hours. A strip pharmacy in Hamilton serves a settled local catchment with stronger front-of-shop sales. Each has a different script rate, rent structure and risk. Most of these tenancies are retail shop leases under the Retail Leases Act 1994 (NSW), so we read the lease as carefully as the accounts.
National business counts point in two directions for a pharmacy. Health care and social assistance businesses increased 6.7 per cent over 2025 to 2026, to 227,702, while retail trade businesses barely moved, up 0.1 per cent (Source: ABS, Counts of Australian Businesses, July 2022 to June 2026, released 18 August 2026). The more of a pharmacy's gross profit comes from dispensing and services rather than the shop floor, the closer it sits to the first of those trends.
The report records its purpose, the standard of value, the valuation date and the records used, including dispensing system reports, and states plainly where any of them fall short. It then explains each approach considered and the method adopted, lists every adjustment with its basis, and draws the results into a range with the weighting explained in words.
That reasoning is tested when partners fall out or a sale ends in court. If the report cannot show why sales evidence outweighed capitalised earnings, or why stock was written down by the amount chosen, an opposing expert will find the gap, whether the matter is in the Supreme Court of New South Wales (which sits in Sydney), the District Court of New South Wales in Newcastle, or turns on the Partnership Act 1892 (NSW) because the partners never signed a deed. Reports are prepared under APESB, APES 225 Valuation Services and signed by a credentialed certified valuer ready to explain and defend the conclusion.
Which figure in my pharmacy valuation is the softest, stock, scripts or the owner's salary, and what evidence holds it in place? If the answer needs a follow-up call, the work is unfinished.
Testing a buyer's approach, or working out what a partnership share might cost before you ask, is what an Indicative valuation is for. It is for internal decision-making and is not written for third party reliance. Use a Summary report for a sale, a partner joining or purchase finance. Use a Detailed report for a family law property settlement, a falling-out between partners, a contested estate such as a family provision claim under Chapter 3 of the Succession Act 2006 (NSW), or any matter another expert will review.
The audience sets the depth. A report likely to reach a judge, a bank, the ATO or an opposing valuer needs to be the fuller one.
For internal decision-making. Useful for testing an offer, setting an expectation before a negotiation, or deciding whether to go to market. It is not written for third party reliance.
Sets out the approaches applied, the normalisation adjustments made and the reasoning behind the conclusion. The usual choice for a sale, an ownership change or a finance application.
Applies and reconciles all relevant approaches in full. The level required where a court, the ATO, a lender or another expert will review the opinion.